Kalman D.S., Feldman S., Samson A., Krieger D.R
We first tested Complex I (CI) activity as the entry point for ETC flux, using a commercial activity assay (Fig
9 AT targeted against the mitochondria The mitochondria are significant producers of reactive species, and mitochondrial damage is one of the major contributors to the onset of various diseases and aging
Projections indicate this market will reach around USD 1.3 billion in 2025, expanding to USD 2.292.6 billion by the early 2030s
The patient continues dosing without therapeutic effect
We did not receive public comments related to the information collection requirements related to ASM, and therefore, we are finalizing provisions as discussed in section III.C of this final rule